Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction
Authors
Keywords
-
Journal
ANTIOXIDANTS & REDOX SIGNALING
Volume 18, Issue 6, Pages 630-641
Publisher
Mary Ann Liebert Inc
Online
2012-03-27
DOI
10.1089/ars.2011.4487
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nicotinamide Phosphoribosyl Transferase/Pre-B Cell Colony-Enhancing Factor/Visfatin Is Required for Lymphocyte Development and Cellular Resistance to Genotoxic Stress
- (2014) A. Rongvaux et al. JOURNAL OF IMMUNOLOGY
- Single Administration of the CXC Chemokine-Binding Protein Evasin-3 During Ischemia Prevents Myocardial Reperfusion Injury in Mice
- (2010) Fabrizio Montecucco et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Silent Information Regulator 1 Protects the Heart From Ischemia/Reperfusion
- (2010) Chiao-Po Hsu et al. CIRCULATION
- Activation of PKN Mediates Survival of Cardiac Myocytes in the Heart During Ischemia/Reperfusion
- (2010) Hiromitsu Takagi et al. CIRCULATION RESEARCH
- Inhibition of Nicotinamide Phosphoribosyltransferase
- (2010) Maria Pittelli et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Plasma and myocardial visfatin expression changes are associated with therapeutic hypothermia protection during murine hemorrhagic shock/resuscitation
- (2010) David G. Beiser et al. RESUSCITATION
- Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis
- (2009) Young Hee Rho et al. ARTHRITIS AND RHEUMATISM
- Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data
- (2009) Anne von Heideman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Nicotinamide Phosphoribosyltransferase Regulates Cell Survival Through NAD + Synthesis in Cardiac Myocytes
- (2009) Chiao-Po Hsu et al. CIRCULATION RESEARCH
- Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans
- (2009) Sheng Wen Liu et al. CLINICAL ENDOCRINOLOGY
- CB2 cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion
- (2009) Fabrizio Montecucco et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice
- (2009) Vincent Braunersreuther et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner
- (2009) Frédéric Van Gool et al. NATURE MEDICINE
- Catastrophic NAD+ Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE
- (2009) Santina Bruzzone et al. PLoS One
- Oxidative stress and left ventricular remodelling after myocardial infarction
- (2008) M. Hori et al. CARDIOVASCULAR RESEARCH
- The novel adipocytokine visfatin exerts direct cardioprotective effects
- (2008) Shiang Y. Lim et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity
- (2008) T. Luk et al. JOURNAL OF LEUKOCYTE BIOLOGY
- SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin
- (2008) Eriko Michishita et al. NATURE
- Circulating visfatin in chronic obstructive pulmonary disease
- (2008) Xiaojing Liu et al. NUTRITION
- Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NAD
- (2008) Nathalie Busso et al. PLoS One
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started